Asha Kulkarni‐Almeida

624 total citations
19 papers, 493 citations indexed

About

Asha Kulkarni‐Almeida is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Asha Kulkarni‐Almeida has authored 19 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Pharmacology and 4 papers in Oncology. Recurrent topics in Asha Kulkarni‐Almeida's work include Microbial Natural Products and Biosynthesis (3 papers), Natural product bioactivities and synthesis (3 papers) and Fungal Biology and Applications (3 papers). Asha Kulkarni‐Almeida is often cited by papers focused on Microbial Natural Products and Biosynthesis (3 papers), Natural product bioactivities and synthesis (3 papers) and Fungal Biology and Applications (3 papers). Asha Kulkarni‐Almeida collaborates with scholars based in India, United States and Canada. Asha Kulkarni‐Almeida's co-authors include Ram A. Vishwakarma, Arun Balakrishnan, Sandip B. Bharate, S. K. Deshmukh, Shilpa A. Verekar, H. Junjappa, Kumar V.S. Nemmani, Nitin Deshmukh, Rajiv Sharma and Usha Ghosh and has published in prestigious journals such as Biochemical and Biophysical Research Communications, American Journal of Physiology-Cell Physiology and European Journal of Pharmacology.

In The Last Decade

Asha Kulkarni‐Almeida

19 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Asha Kulkarni‐Almeida India 13 212 163 123 98 50 19 493
Elizabeth W. Chia New Zealand 11 157 0.7× 176 1.1× 75 0.6× 57 0.6× 14 0.3× 15 470
Yuanli Li China 12 231 1.1× 38 0.2× 52 0.4× 22 0.2× 25 0.5× 28 436
Jie Shi China 12 203 1.0× 52 0.3× 43 0.3× 24 0.2× 43 0.9× 23 349
Liu Zeng Chen China 11 171 0.8× 192 1.2× 67 0.5× 16 0.2× 18 0.4× 14 411
Yuh‐Chi Kuo Taiwan 9 140 0.7× 40 0.2× 164 1.3× 15 0.2× 80 1.6× 12 452
Yuan Qing Qu Macao 14 284 1.3× 83 0.5× 54 0.4× 13 0.1× 31 0.6× 20 491
Ashley Boice United States 3 279 1.3× 49 0.3× 27 0.2× 26 0.3× 15 0.3× 7 397
Smiti Gupta United States 16 391 1.8× 70 0.4× 56 0.5× 7 0.1× 13 0.3× 37 658
Katharina Hofheinz Germany 7 223 1.1× 90 0.6× 87 0.7× 4 0.0× 26 0.5× 10 480
Dyral C. Fessler United States 7 383 1.8× 134 0.8× 51 0.4× 13 0.1× 24 0.5× 10 657

Countries citing papers authored by Asha Kulkarni‐Almeida

Since Specialization
Citations

This map shows the geographic impact of Asha Kulkarni‐Almeida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asha Kulkarni‐Almeida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asha Kulkarni‐Almeida more than expected).

Fields of papers citing papers by Asha Kulkarni‐Almeida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asha Kulkarni‐Almeida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asha Kulkarni‐Almeida. The network helps show where Asha Kulkarni‐Almeida may publish in the future.

Co-authorship network of co-authors of Asha Kulkarni‐Almeida

This figure shows the co-authorship network connecting the top 25 collaborators of Asha Kulkarni‐Almeida. A scholar is included among the top collaborators of Asha Kulkarni‐Almeida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asha Kulkarni‐Almeida. Asha Kulkarni‐Almeida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ghosh, Usha, Rajiv Sharma, Asha Kulkarni‐Almeida, et al.. (2017). Discovery of tetrahydrocarbazoles as dual pERK and pRb inhibitors. European Journal of Medicinal Chemistry. 134. 366–378. 14 indexed citations
2.
Kulkarni‐Almeida, Asha, et al.. (2016). A semi-synthetic natural product blocks collagen induced arthritis by preferentially suppressing the production of IL-6. International Immunopharmacology. 33. 63–69. 1 indexed citations
4.
Kate, Abhijeet S., et al.. (2015). NFAT-133 increases glucose uptake in L6 myotubes by activating AMPK pathway. European Journal of Pharmacology. 769. 117–126. 13 indexed citations
5.
Kulkarni‐Almeida, Asha, et al.. (2015). Screening of Microbial Extracts for Anticancer Compounds Using Streptomyces Kinase Inhibitor Assay. Natural Product Communications. 10(7). 1287–91. 5 indexed citations
6.
Deshmukh, S. K., et al.. (2015). Anti-inflammatory properties of mutolide isolated from the fungus Lepidosphaeria species (PM0651419). SpringerPlus. 4(1). 706–706. 9 indexed citations
7.
Prabhu, K. Narayan, Shilpa A. Verekar, Asha Kulkarni‐Almeida, et al.. (2013). Note Anti-inflammatory and anti-diabetic naphtha- quinones from an endophytic fungus Dendryphion nanum (Nees) S. Hughes. 52(4). 565–567. 1 indexed citations
8.
Kharkar, Prashant S., et al.. (2013). Discovery of thiazolyl-phthalazinone acetamides as potent glucose uptake activators via high-throughput screening. Bioorganic & Medicinal Chemistry Letters. 23(20). 5740–5743. 17 indexed citations
9.
Khanna, Smriti, Ashish P. Keche, Usha Ghosh, et al.. (2012). Isocytosine-based inhibitors of xanthine oxidase: Design, synthesis, SAR, PK and in vivo efficacy in rat model of hyperuricemia. Bioorganic & Medicinal Chemistry Letters. 22(24). 7543–7546. 45 indexed citations
10.
Hegde, Bindu, et al.. (2012). Vitamin E is a MIF Inhibitor. Biochemical and Biophysical Research Communications. 418(2). 384–389. 8 indexed citations
11.
Keche, Ashish P., Usha Ghosh, Smriti Khanna, et al.. (2012). Lead optimization of isocytosine-derived xanthine oxidase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(3). 834–838. 29 indexed citations
12.
Saklani, Arvind, Bindu Hegde, Ruchi Singh, et al.. (2012). NF-κB dependent anti-inflammatory activity of chlorojanerin isolated from Saussurea heteromalla. Phytomedicine. 19(11). 988–997. 16 indexed citations
13.
B‐Rao, Chandrika, Asha Kulkarni‐Almeida, Smriti Khanna, et al.. (2012). Identification of novel isocytosine derivatives as xanthine oxidase inhibitors from a set of virtual screening hits. Bioorganic & Medicinal Chemistry. 20(9). 2930–2939. 50 indexed citations
14.
Kulkarni‐Almeida, Asha, Manoja K. Brahma, K. Narayan Prabhu, et al.. (2011). Fermentation, Isolation, Structure, and Antidiabetic Activity of NFAT-133 produced by Streptomyces strain PM0324667. AMB Express. 1(1). 42–42. 28 indexed citations
15.
Dagia, Nilesh M., et al.. (2010). A preferential p110α/γ PI3K inhibitor attenuates experimental inflammation by suppressing the production of proinflammatory mediators in a NF-κB-dependent manner. American Journal of Physiology-Cell Physiology. 298(4). C929–C941. 41 indexed citations
16.
Deshmukh, S. K., Asha Kulkarni‐Almeida, Shilpa A. Verekar, et al.. (2009). Anti‐Inflammatory and Anticancer Activity of Ergoflavin Isolated from an Endophytic Fungus. Chemistry & Biodiversity. 6(5). 784–789. 73 indexed citations
17.
Bharate, Sandip B., Atish H. Rodge, Jaspreet Kaur, et al.. (2008). Discovery of diacylphloroglucinols as a new class of GPR40 (FFAR1) agonists. Bioorganic & Medicinal Chemistry Letters. 18(24). 6357–6361. 29 indexed citations
19.
Bharate, Sandip B., et al.. (2008). Synthesis and evaluation of pyrazolo[3,4-b]pyridines and its structural analogues as TNF-α and IL-6 inhibitors. Bioorganic & Medicinal Chemistry. 16(15). 7167–7176. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026